Protective Effects of Butyrate on Cerebral Ischaemic Injury in Animal Models: a Systematic Review and Meta-analysis

Overview

Journal Front Neurosci

Date 2024 Mar 15

PMID 38486971

Authors

Shichang Yan

Qipei Ji

Jilin Ding

Zhixiang Liu

Wei Wei

Huaqiang Li

Luojie Li

Chuan Ma

Defu Liao

Ziyan He

Shuangchun Ai

Affiliations

Soon will be listed here.

Abstract

Introduction: Cerebral ischaemic stroke is a common disease that poses a serious threat to human health. Butyrate is an important metabolite of intestinal microorganisms. Recent studies have shown that butyrate has a significant protective effect in animal models of cerebral ischaemic injury.

Objective: The aim of this study was to evaluate the protective effect of butyrate on cerebral ischaemic stroke by meta-analysis, aiming to provide a scientific basis for the clinical application of butyrate in patients with cerebral ischaemia.

Materials And Methods: A systematic search was conducted for all relevant studies published before 23 January 2024, in PubMed, Web of Science, Cochrane Library, and Embase. Methodological quality was assessed using Syrcle's risk of bias tool for animal studies. Data were analysed using Rev Man 5.3 software.

Results: A total of nine studies were included, and compared with controls, butyrate significantly increased BDNF levels in the brain (SMD = 2.33, 95%CI = [1.20, 3.47], < 0.005) and P-Akt expression (SMD = 3.53, 95% CI = [0.97, 6.10], < 0.05). Butyrate also decreased IL-β levels in the brain (SMD = -2.02, 95% CI = [-3.22, -0.81], < 0.005), TNF-α levels (SMD = -0.86, 95% CI = [-1.60, -0.12], < 0.05), and peripheral vascular IL-1β levels (SMD = -2.10, 95%CI = [-3.59, -0.61], < 0.05). In addition, butyrate reduced cerebral infarct volume (MD = -11.29, 95%CI = [-17.03, -5.54], < 0.05), mNSS score (MD = -2.86, 95%CI = [-4.12, -1.60], < 0.005), foot fault score (MD = -7.59, 95%CI = [-9.83, -5, 35], < 0.005), and Morris water maze time (SMD = -2.49, 95%CI = [-4.42, -0.55], < 0.05).

Conclusion: The results of this study indicate that butyrate has a protective effect on cerebral ischaemic stroke in animal models, and the mechanism is related to reducing inflammation and inhibiting apoptosis. It provides an evidence-based basis for the future clinical development of butyrate in the treatment of ischaemic stroke.

Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/, CRD42023482844.

References

Kilkenny C, Browne W, Cuthill I, Emerson M, Altman D . Animal research: reporting in vivo experiments--the ARRIVE guidelines. J Cereb Blood Flow Metab. 2011; 31(4):991-3. PMC: 3070981. DOI: 10.1038/jcbfm.2010.220. View

Chen Z, Xin L, Yang L, Xu M, Li F, Zhou M . Butyrate promotes post-stroke outcomes in aged mice via interleukin-22. Exp Neurol. 2023; 363:114351. DOI: 10.1016/j.expneurol.2023.114351. View

Campbell B, De Silva D, Macleod M, Coutts S, Schwamm L, Davis S . Ischaemic stroke. Nat Rev Dis Primers. 2019; 5(1):70. DOI: 10.1038/s41572-019-0118-8. View

Qin W, Li J, Zhu R, Gao S, Fan J, Xia M . Melatonin protects blood-brain barrier integrity and permeability by inhibiting matrix metalloproteinase-9 via the NOTCH3/NF-κB pathway. Aging (Albany NY). 2019; 11(23):11391-11415. PMC: 6932927. DOI: 10.18632/aging.102537. View

Li T, Zhao D, Wei Y, Li J, Li X, Wan Q . Effect and Mechanism of Sodium Butyrate on Neuronal Recovery and Prognosis in Diabetic Stroke. J Neuroimmune Pharmacol. 2023; 18(3):366-382. DOI: 10.1007/s11481-023-10071-0. View

Park J, Kim M, Kang S, Jannasch A, Cooper B, Patterson J . Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol. 2014; 8(1):80-93. PMC: 4263689. DOI: 10.1038/mi.2014.44. View

Wytrykowska A, Prosba-Mackiewicz M, Nyka W . IL-1β, TNF-α, and IL-6 levels in gingival fluid and serum of patients with ischemic stroke. J Oral Sci. 2016; 58(4):509-513. DOI: 10.2334/josnusd.16-0278. View

Zhou Z, Xu N, Matei N, McBride D, Ding Y, Liang H . Sodium butyrate attenuated neuronal apoptosis via GPR41/Gβγ/PI3K/Akt pathway after MCAO in rats. J Cereb Blood Flow Metab. 2020; 41(2):267-281. PMC: 8370004. DOI: 10.1177/0271678X20910533. View

Ridler C . Gut microbiota: Gut bacteria affect post-ischaemic inflammation in stroke by modulating intestinal T cells. Nat Rev Gastroenterol Hepatol. 2016; 13(5):250. DOI: 10.1038/nrgastro.2016.64. View

10.

Weber A, Wasiliew P, Kracht M . Interleukin-1 (IL-1) pathway. Sci Signal. 2010; 3(105):cm1. DOI: 10.1126/scisignal.3105cm1. View

11.

Wang H, Zhang M, Li J, Liang J, Yang M, Xia G . Gut microbiota is causally associated with poststroke cognitive impairment through lipopolysaccharide and butyrate. J Neuroinflammation. 2022; 19(1):76. PMC: 8981610. DOI: 10.1186/s12974-022-02435-9. View

12.

Kim H, Rowe M, Ren M, Hong J, Chen P, Chuang D . Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther. 2007; 321(3):892-901. DOI: 10.1124/jpet.107.120188. View

13.

Malkki H . Stroke: Gut microbiota influence stroke recovery in mice. Nat Rev Neurol. 2016; 12(5):252. DOI: 10.1038/nrneurol.2016.52. View

14.

Nedjadi T, Moran A, Al-Rammahi M, Shirazi-Beechey S . Characterization of butyrate transport across the luminal membranes of equine large intestine. Exp Physiol. 2014; 99(10):1335-47. DOI: 10.1113/expphysiol.2014.077982. View

15.

Emsley H, Smith C, Gavin C, Georgiou R, Vail A, Barberan E . Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC Neurol. 2007; 7:5. PMC: 1810309. DOI: 10.1186/1471-2377-7-5. View

16.

Wang H, Song W, Wu Q, Gao X, Li J, Tan C . Fecal Transplantation from db/db Mice Treated with Sodium Butyrate Attenuates Ischemic Stroke Injury. Microbiol Spectr. 2021; 9(2):e0004221. PMC: 8510264. DOI: 10.1128/Spectrum.00042-21. View

17.

Peng L, Li Z, Green R, Holzman I, Lin J . Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr. 2009; 139(9):1619-25. PMC: 2728689. DOI: 10.3945/jn.109.104638. View

18.

Yamashiro K, Tanaka R, Urabe T, Ueno Y, Yamashiro Y, Nomoto K . Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke. PLoS One. 2017; 12(2):e0171521. PMC: 5293236. DOI: 10.1371/journal.pone.0171521. View

19.

Wang H, Wang P, Wang X, Wan Y, Liu Y . Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription. Dig Dis Sci. 2012; 57(12):3126-35. DOI: 10.1007/s10620-012-2259-4. View

20.

Sun J, Wang F, Li H, Zhang H, Jin J, Chen W . Neuroprotective Effect of Sodium Butyrate against Cerebral Ischemia/Reperfusion Injury in Mice. Biomed Res Int. 2015; 2015:395895. PMC: 4439479. DOI: 10.1155/2015/395895. View